Answers are grounded in this paper and cite their sources.
Nutritional care is an important part of the management of patients with chronic kidney disease (CKD), including ones on maintenance dialysis and with kidney transplantation [1, 2]. As a whole, nutrition management can improve or prevent many of the metabolic derangements that will commonly appear during the progression of kidney disease and potentially preserve kidney function and delay initiation of renal replacement therapy (Figure 1). However, in order for the dietary interventions to work, patients must comply with them, should be trained to do so and should be appropriately followed to ensure efficacy or limit potential side effects. In addition, the best target populations of patients with CKD should also be identified. Beneficial effects of an optimal renal diet at different CKD stages. The Kidney Disease Outcomes Quality Initiative and Academy of Nutrition and Dietetics have recently published an update to the Clinical Practice Guideline for Nutrition in patients with CKD [3]. Notwithstanding the upcoming results of this initiative, the most critical component of this process is implementation, the development of effective strategies to improve health-related processes and outcomes (Table 1). Successful implementation of guidelines will result in the production of generalizable knowledge in processes, barriers, facilitators and strategies. Prescription of low- or very low-protein diets has been a well-known nutritional strategy to improve the metabolic profile of patients with moderate to advanced CKD and is likely to have a significant presence in the most recent updated guidelines. On the other hand, implementation of restricted protein diets in clinical practice has been challenging to say the least. In this commentary, potential barriers to the implementation process of low- and very low-protein diets will be discussed in order to provide examples for other nutritional strategies that might be included in the upcoming and future nutrition guidelines in patients with CKD. Implementing a low-protein diet during CKD: major targets of action Convincing data Convince teachers: editors, opinion leaders, scientific societies, lobbying Convince doctors Convince dietitians Convince patients Convince funding bodies Convincing data Convince teachers: editors, opinion leaders, scientific societies, lobbying Convince doctors Convince dietitians Convince patients Convince funding bodies Implementing a low-protein diet during CKD: major targets of action Convincing data Convince teachers: editors, opinion leaders, scientific societies, lobbying Convince doctors Convince dietitians Convince patients Convince funding bodies Convincing data Convince teachers: editors, opinion leaders, scientific societies, lobbying Convince doctors Convince dietitians Convince patients Convince funding bodies An important barrier to clinical implementation is the nature of information and how it is communicated to patients. Scientifically convincing data continue to accumulate. The last two recent large-scale studies from Metzger et al. [4] and Garneata et al. [5] showed that patients who eat less protein on a daily basis (without any physician intervention) start dialysis later than those eating more protein [4] and eating a very low-protein diet with amino acid/ketoacid supplements over 1 year reduces the need for initiation of dialysis by 20% [5]. Patients can easily understand these data when convincingly presented by the staff. Indeed, convincing patients can best be accomplished by nephrologists who have been able to set up a CKD care programme, kidney clinic or other global approach for chronic kidney management. Obviously, due to the commitment that is required, some patients may not be the ideal candidates. Indeed, a fair view of compliance with protein restriction is approximately 60–70%. Interestingly, this number compares with the average compliance with any drug in the general population as well as in CKD patients. Motivation, support and dietary interviews will be necessary for the patient to cope with the diet without making errors, such as excessively reducing energy intake. To better define the optimal level of protein restriction accepted by the patient, a gradual reduction in protein intake may be applied. Patients should be advised to taper down protein intake from 1 g/kg/day to 0.8, 0.6 then 0.4 g/kg/day over 6 months. This allows the patient to identify at which protein intake level he/she feels comfortable. The rapid decrease in blood urea nitrogen may improve patient wellness and quality of life so that he/she may decide to lower protein intake further. At this point, a regular nutritional check-up including body weight and dietary interviews should be done every 3 months to ensure good nutritional health. Acceptance of a very low-protein intake (0.3 g/kg/day) may be limited to 15–20% of patients [5], but other patients will still benefit from a reduced protein load and low toxin generation. Finally, acceptance of protein reduction interventions seems improved inside well-organized renal care clinics [6]. Despite strong scientific evidence that has been accumulating, many doctors are still unconvinced that a low-protein diet can help patients with CKD. The reasons for this nihilism are unclear but could be related to insufficient background knowledge, lack of interest in nutrition and dietetics, limited familiarity with the most recent literature and possibly still being under the influence of dated data that suggest inefficacy, albeit based on an inadequately designed trial [7]. In a recent short US survey, while 69% of nephrologists would not propose protein restriction, 81% of them were interested in learning more and asked for more renal dietitians [8]. Another underappreciated fact is that most physicians are unequipped when it comes to providing information to patients on how to select food in grocery stores or how to cook for the greatest nutritional benefits. Understandably, in the limited time during which CKD patients are seen, dietary information may not be considered a major therapeutic management point given the medical complexity of patients with moderate to advanced CKD. Interestingly, the habit of referring CKD patients to a dietitian with expertise in kidney disease is hard to establish within the nephrology community but could be a simple, straightforward solution to overcome this barrier. Obviously dietitians are fully convinced that the appropriate selection of nutrients for daily living is mandatory for maintaining a good health. However, few dietitians have been trained in the characteristics of CKD, and most of them are busy taking care of patients with diabetes and obesity. In addition, the increasing administrative workload has considerably reduced the time offered to patients [9, 10]. Although most guidelines in nutrition and kidney diseases have highlighted the importance of working with renal dietitians for long-term management of patients with CKD, including ones on maintenance dialysis and with a kidney transplant [11], few programmes can offer this holistic care model [12]. Convincing the payors to buy into nutritional interventions should be done as well. Maintenance dialysis is a very expensive treatment, accounting for several percent of many underdeveloped country’s medical expenses. The yearly cost of maintenance haemodialysis is thousands of euros per patient, and up to €80 000 in France. Because of a limited toxin generation associated with a reduced protein intake, better control of blood pressure, phosphate and calcium metabolism and acidosis can be achieved and initiation of dialysis can be postponed for many months or even years in certain patients. A Markov cost-effectiveness analysis performed in Italy reported billions of euros could be saved at the country level by postponing the start of dialysis if half of the country's patients had followed a very low-protein diet [13]. This observation from Italy can certainly be expanded to many countries worldwide. In summary, despite evidence of efficacy [3] and a low side effect profile, few patients with moderate to severe CKD are allowed to benefit from personalized dietary care. Beyond patients, implementation should target all involved individuals to provide routine but crucial dietary management for patients with CKD worldwide. D.F. declares speaker and travel fees from Amgen, Fresenius Medical Care, Fresenius Kabi, Sanofi and Vifor outside of this research. T.A.I. is a consultant and received honoraria for his work from Abbott Renal Care, Fresenius Kabi and Nestle.
No takes yet. Share an insight, caveat, or question.
Fouque et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: